Application of ellagic acid to preparation of drugs for treating and preventing fungal infection of human body
A fungal infection, ellagic acid technology, applied in the direction of antibacterial drugs, antifungal agents, medical preparations containing active ingredients, etc., can solve problems such as difficult to control, liver toxicity, kidney toxicity, etc.
Active Publication Date: 2014-03-12
XINJIANG BIOCHEM PHARMA CO LTD
View PDF1 Cites 3 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
[0004] With the progress of society and the improvement of people's living standards, people pay more and more attention to health and quality of life. Fungal infection is a common and frequently-occurring disease, and it has gradually increased in recent years. However, with the widespread use of antifungal agents application, clinical drug-resistant strains are increasing, coupled with the increasing resistance of pathogenic fungi to existing drugs, making fungal infections easy to occur and difficult to control
The antifungal drugs currently used clinically have played a role in controlling pathogenic fungal infections to a certain extent, but there are still many deficiencies, such as amphotericin B has severe nephrotoxicity; The cytochrome P450 system of animals also has an inhibitory effect, which in turn produces toxic and side effects, and a small number of users may also have severe liver toxicity; ketoconazole, fluconazole, itraconazole, etc. have all caused liver necrosis or hepatotoxicity to death report
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More
Abstract
The invention relates to an application of ellagic acid to preparation of drugs for treating and preventing fungal infection of a human body. According to the application, the in-vitro fungi inhibition activity of ellagic acid to 23 fungi is studied and the MIC (minimal inhibitory concentration) value is measured; an in-vitro activity result of ellagic acid to the fungi shows that the MIC value of ellagic acid to 6 dermatophytes is 6.25-50 microgram / ml, and ellagic acid has a better inhibition effect on clinical common superficial pathogenic fungi and is especially sensitive to trichophyton rubrum; the MIC value of ellagic acid to 6 clinical common candida is 25-200 microgram / ml; ellagic acid is orally taken and externally used to treat a cavy skin trichophyton rubrum infection model, and the effect of treating a mouse fungal infection model by injecting ellagic acid or ellagic acid and fluconazole is studied; a study result shows that ellagic acid has a certain treatment effect on the cavy skin trichophyton rubrum infection model after being orally taken and externally used.
Description
technical field [0001] The invention relates to the application of ellagic acid in the preparation of medicines for treating and preventing human fungal infection diseases. Background technique [0002] The molecular formula of ellagic acid is C14H6O8, English name: ellagic acid, chemical name: 2,3,7,8-tetrahydroxy benzopyrano-5,4,3-cde benzopyran-5,10-dione. Slightly soluble in water and alcohol, soluble in alkali and pyridine, insoluble in ether. [0003] Ellagic acid can be obtained by extracting plants such as Dijincao, Bandijin, blackberry, raspberry, strawberry, cranberry, pecan, pomegranate, wolfberry, etc., and can also be obtained by chemical synthesis. [0004] With the progress of society and the improvement of people's living standards, people pay more and more attention to health and quality of life. Fungal infection is a common and frequently-occurring disease, and it has gradually increased in recent years. However, with the widespread use of antifungal agent...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/366A61P31/10A61P31/04
Inventor 斯拉甫·艾白李治建古力娜·达吾提
Owner XINJIANG BIOCHEM PHARMA CO LTD
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com